WBI Investments’s Elevance Health ELV Stock Holding History

WBI Investments’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,816	Closed	-$1.22M	–	285
2025 Q1	$1.22M	Buy	+2,816	New	+$1.13M	0.32%	88
2024 Q2	–	Sell	-1,567	Closed	-$812K	–	187
2024 Q1	$812K	Buy	+1,567	New	+$779K	0.17%	116
2023 Q1	–	Sell	-2,657	Closed	-$1.36M	–	194
2022 Q4	$1.36M	Buy	+2,657	New	+$1.35M	0.29%	81
2022 Q2	–	Sell	-16,761	Closed	-$7.95M	–	141
2022 Q1	$7.95M	Buy	16,761 +13,005	+346%	+$5.94M	1.29%	18
2021 Q4	$1.63M	Buy	+3,756	New	+$1.58M	0.26%	88
2020 Q1	–	Sell	-2,580	Closed	-$779K	–	124
2019 Q4	$779K	Buy	+2,580	New	+$710K	0.08%	138
2018 Q4	–	Sell	-5,949	Closed	-$1.63M	–	134
2018 Q3	$1.63M	Sell	5,949 -2,865	-33%	-$744K	0.09%	171
2018 Q2	$2.1M	Buy	+8,814	New	+$2.04M	0.11%	125
2017 Q3	–	Sell	-56,233	Closed	-$10.6M	–	316
2017 Q2	$10.6M	Buy	56,233 +48,609	+638%	+$8.73M	0.46%	45
2017 Q1	$1.26M	Buy	+7,624	New	+$1.21M	0.06%	188

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

WBI Investments's ELV Position: Q2 2025 in Review

WBI Investments sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 2,816 shares — an estimated $1.22M sold.

WBI Investments first reported a position in ELV in Q1 2017 and held it in 10 quarters. The position peaked at $10.6M in Q2 2017. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

WBI Investments reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
WBI Investments sold 2,816 Elevance Health shares in Q2 2025, an estimated $1.22M.
WBI Investments first reported a position in Elevance Health in Q1 2017 and held it in 10 quarters.
WBI Investments's Elevance Health position peaked at $10.6M in Q2 2017.
1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on WBI Investments's 13F filing for Q2 2025, filed 11 Aug 2025.